Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-18 · accession 0001209191-22-004200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-20 | 2022-01-18 | PCRX | Riker Lauren Bullaro | SVP, Fin | M - OptEx | $10.81 | +2,500 | 17.7K | +16% | +$27.0K |
| D | 2022-01-20 | 2022-01-18 | PCRX | Riker Lauren Bullaro | SVP, Fin | S - Sale+OE | $64.97 | -2,500 | 15.2K | -14% | -$162.4K |
| D | 2022-01-20 | 2022-01-18 | PCRX | Riker Lauren Bullaro | SVP, Fin | M - OptEx | $0.00 | -2,500 | 9,300 | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-18 | M | A | 2,500 | $10.81 | 17,652 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-18 | S | D | 2,500 | $64.97 | 15,152 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-01-18 | M | D | 2,500 | $0.00 | 9,300 | D | $10.81 · — to 2022-06-05 | 2,500 Common Stock | (F2) The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. |